ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625737 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625737; 2) Community: the network communities that were significantly associated with the response to NSC 625737; 3) Molecule: the relationships between components within communities and NSC 625737; 4) MDR: the compounds that were significantly associated with the NSC 625737.

NSC Compound Enrichment Correlation
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.00359493104490023 0.11760915
NSC 105023 RUBIFLAVIN 0.00404192617431249 0.42591469
NSC 17551 1,3-Propanedione, 1-(3-pyridinyl)-3-(2,4,6-trimethyl- phenyl)- 0.00404192617431249 0.48540651
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.00404192617431249 0.53210965
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.00404192617431249 0.46617658
NSC 373355 Saframycin R 0.00404192617431249 0.0011625083
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.00404192617431249 0.39114316
NSC 529108 4-Fluoro-D,L-tryptophan 0.00404192617431249 0.46200185
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.00404192617431249 0.50316278
NSC 602313 Null 0.00404192617431249 0.63077471
Total:129  Current:19    [First] [Prev] [Next] [Last]